About This 510(k) Submission
K212620 is an FDA 510(k) clearance for the Citrasate Liquid Acid Concentrate, NaturaLyte Liquid Acid Concentrate, a Dialysate Concentrate For Hemodialysis (liquid Or Powder) (Class II — Special Controls, product code KPO), submitted by Fresenius Medical Care Renal Therapies Group, LLC (Waltham, US). The FDA issued a Cleared decision on May 12, 2022, 267 days after receiving the submission on August 18, 2021. This device falls under the Gastroenterology & Urology review panel. Regulated under 21 CFR 876.5820.